New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.
Start Your Search

Pharma Company Blocks Nevada Execution

A New-Jersey based pharmaceutical company successfully prevented its drugs from being used in a Nevada execution.

For the past decade, pharmaceutical companies have cited ethical and legal reasons to block their drugs being used in lethal injections. A recent CNBC article noted the most recent case in which a twice-convicted killer wanted to be put to death, but a last-minute lawsuit from Alvogen, maker of one of the drugs in the three-drug injection, prevented it.

Alvogen claimed via court documents that Nevada prison officials illegally obtained the sedative midazolam, and the company doesn’t want its product used in a “botched” execution. “Midazolam is not approved for use in such an application,” the document said. The drug was substituted in May to replace expired prison stocks of diazemab, a similar sedative also known as Valium.

Last year, an execution fiasco in Arkansas left drug manufacturers scrambling to figure out how the state's Department of Correction got their hands on a supply of lethal injection drugs. 

Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Unlock Learning Here
Discover Our Content Hub
Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Take Quiz
Test Your Supply Chain Smarts